You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Continue

News

How cutting-edge gassing isolators help one healthcare provider to treat cancer patients at home

How cutting-edge gassing isolators help one healthcare provider to treat cancer patients at home

Sterile preparation of essential medicines in controlled aseptic environments is crucial when treating cancer patients at home. In the UK, thousands of cancer patients receive safe, convenient treatment from the comfort of their own homes thanks to a sterility collaboration between the country’s largest provider of cancer care at home, Sciensus, and Swedish medtech provider Getinge.

Sterile preparation of essential medicines in controlled aseptic environments is crucial when treating cancer patients at home. In the UK, thousands of cancer patients receive safe, convenient treatment from the comfort of their own homes thanks to a sterility collaboration between the country’s largest provider of cancer care at home, Sciensus, and Swedish medtech provider Getinge.

The ability to mix – or compound – drugs in sterile conditions is paramount when treating and medicating people with serious diseases such as cancer. Sciensus provides treatment to more than 200,000 patients across the UK, some of whom have cancer. The company’s service depends on its capacity to prepare individualised medications for each patient in rigorously controlled aseptic conditions.

Sciensus makes medicines for ready-to-administer infusion bags, syringes and infusion devices. To ensure sterility, the compounding process takes place inside two Getinge glove isolators, each equipped with a bio-decontamination chamber where hydrogen peroxide sanitises all product surfaces to ensure a high degree of sterility assurance, with a proven 6-log reduction of bioburden and the highest hygiene standards.

Best-in-class equipment for highest assurance

“We aim at all times to provide a premium service to our patients and that means using best-in-class equipment and facilities. Our isolators provide us with the high level of sterility assurance we need to serve our patients,” says Jo Gautam, Accountable Pharmacist at Sciensus.

Transferring material into and out of isolators requires specialist technologies.

Getinge’s GMP ISOFLEX-R isolators come with a DPTE® transfer system that uses a RTP or Alpha-Beta transfer port that allows material to be moved from one sterile zone to another through a non-sterile zone, with leak-tight, risk-free reconnection.

The DPTE solution is now the gold standard for the production of aseptic or toxic products in pharmaceutical factories and biomedical research, says Jonathan Grogan, National Sales Manager Life Science at Getinge UK.

“Isolators may be required to protect a process from the environment, for example in the case of aseptic production, or the environment from the process – for instance when handling toxic materials,” he explains. “In some cases, such as preparation of cytotoxic injectables for cancer treatment, it may be both.”

Read the full story via the PDF below.

Files

Share: